A carregar...
Update on TDM (Therapeutic Drug Monitoring) with Ustekinumab, Vedolizumab and Tofacitinib in Inflammatory Bowel Disease
The goal of therapeutic drug monitoring (TDM) is to optimize anti-TNF (tumor necrosis factor) biologic treatment in patients with inflammatory bowel disease (IBD). Although commercial assays are readily available for both ustekinumab and vedolizumab, the use of TDM with these newer biologic medicati...
Na minha lista:
| Publicado no: | J Clin Med |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8002563/ https://ncbi.nlm.nih.gov/pubmed/33802816 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10061242 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|